Search clinical trials for: Dehydroepiandrosterone (DHEA)

Total 452 results

The University of Hong Kong

Completed

Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVF

Female Infertility Due to Diminished Ovarian Reserve

Hong Kong
EndoCeutics Inc.

Completed

Topical DHEA Against Vaginal Atrophy

Vaginal Atrophy

United States, Canada
Inflabloc Pharmaceuticals

Completed

An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease

Crohn's Disease

United States, Canada
University of Helsinki
Uppsala University; Göteborg University

Unknown

Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue

Sjogren's Syndrome

Finland
Taipei Veterans General Hospital, Taiwan
National YangMing University

Completed

Effects of Dehydroepiandrosterone Supplementation on Cumulus Cells Gene Expression Under Controlled Ovarian Hyper-stimulation in Patients With Diminished Ovarian Reserve

Dehydroepiandrosterone | DHEAS | Gene Expression of Cumulus Cells. | Ovarian Hyper-stimulation Protocol. | Artificial Reproduction Technology.

Taiwan
EndoCeutics Inc.

Completed

Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy

Vaginal Atrophy

United States, Canada
Monash University

Completed

Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms

Quality of Life | Menopausal Syndrome | Libido Disorder

Australia
University of Michigan
Arthritis Foundation

Completed

Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention

Systemic Lupus Erythematosus

United States
EndoCeutics Inc.

Completed

DHEA Against Vaginal Atrophy - Safety Study of 12 Months

Vaginal Atrophy

United States, Canada
CHU de Quebec-Universite Laval

Completed

DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy

Vaginal Atrophy

Canada
EndoCeutics Inc.

Completed

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study

Vaginal Atrophy

United States, Canada
Chinese Medical Association

Completed

Effect of Dehydroepiandrosterone Administration in Patients With Poor Ovarian Response According to the Bologna Criteria

Infertility

China
Jed E. Rose

Completed

The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers (DHEA)

Substance Withdrawal Syndrome

United States
ShangHai Ji Ai Genetics & IVF Institute

Unknown

The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation in Poor Responders (DHEA)

Infertility

China
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Terminated

DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer

United States
Royal College of Surgeons, Ireland
University of Oxford; University of Birmingham

Recruiting

Dissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS) (DIMOXIS)

Endocrine System Diseases | Polycystic Ovary Syndrome | Insulin Resistance | Androgen; Hypersecretion

Ireland
Kaohsiung Veterans General Hospital.

Completed

Dehydroepiandrosterone Maintain Mitochondrial Quality of Cumulus Cells in Poor Ovarian Responders

Poor Responders | Dehydroepiandrosterone

Taiwan
Mayo Clinic

Completed

Effects of Androgen Administration on Inflammation in Normal Women

Hyperandrogenism

United States
University of Aarhus

Completed

Six Months DHEA Treatment in Female Adrenal Failure

Adrenal Insufficiency
EndoCeutics Inc.

Completed

Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women

Vasomotor Symptoms | Hot Flushes

Canada
Humanetics Corporation

Completed

7-Keto DHEA for the Treatment of PTSD

PTSD

United States
University of Colorado, Denver
National Institute on Aging (NIA)

Recruiting

DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women

Osteoporosis, Postmenopausal | Low Bone Mass

United States
Indiana University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Evaluate Pharmacokinetics and Safety of Slow Release DHEA (DHEA)

Asthma | Genotype

United States
Rhode Island Hospital

Active, not recruiting

Effects of DHEA in Pulmonary Hypertension (EDIPHY)

Pulmonary Arterial Hypertension

United States
David H. Barad

Terminated

Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF) (DHEAFert2)

Premature Ovarian Failure

United States
Tel-Aviv Sourasky Medical Center

Unknown

Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder

Hypoactive Sexual Desire Disorder

Israel
University Hospital, Bordeaux

Completed

Study of Dehydroepiandrosterone (DHEA) in Respiratory Pulmonary Hypertension in Adults

Chronic Obstructive Pulmonary Disease | Hypertension, Pulmonary

France
ShangHai Ji Ai Genetics & IVF Institute

Completed

Dehydroepiandrosterone (DHEA)Supplementation Pre-IVF(In Vitro Fertilization) Cycles (IVF)

Infertility
EndoCeutics Inc.

Completed

Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause

Vaginal Atrophy

United States, Canada
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT) (ARTT)

Estrogen Receptor Positive Breast Cancer | Androgen Receptor Gene Overexpression | Progesterone Receptor Positive Tumor | Metastatic Breastcancer | Estrogen Receptor Negative Neoplasm | Progesterone Receptor Negative Neoplasm

Italy
University of Maryland, Baltimore
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus

Type 1 Diabetes

United States
National Aeronautics and Space Administration (NASA)
University of Connecticut

Completed

Effects of DHEA/Exercise on Bone, Muscle and Balance

Frailty | Osteoporosis

United States
Center for Vulvovaginal Disorders
EndoCeutics Inc.

Unknown

Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy

Menopause | Vulvovaginal Atrophy | Dyspareunia | Genitourinary Syndrome of Menopause | Menopause Syndrome

United States
EndoCeutics Inc.
AMAG Pharmaceuticals, Inc.

Withdrawn

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer

Vaginal Atrophy in Breast Cancer Patients
Hospital Clinic of Barcelona

Completed

Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors (VIBRA)

Breast Cancer | Genitourinary Syndrome of Menopause | Vulvar Atrophy

Spain
University of Maryland, Baltimore

Recruiting

The Effects of Fluoxetine and/or DHEA

Type 1 Diabetes Mellitus

United States
Olivia Cardenas-Trowers, M.D.
AMAG Pharmaceuticals, Inc.

Withdrawn

Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women

Menopause | Postmenopause | Recurrent Urinary Tract Infection | Postmenopausal Symptoms | Postmenopausal Syndrome

United States
Washington University School of Medicine

Terminated

DHEA in Synovial Sarcoma Patients

Synovial Sarcoma | Sarcoma, Synovial

United States
The Affiliated Hospital of Inner Mongolia Medical...
First Affiliated Hospital, Sun Yat-Sen University; Renmin Hospital of Wuhan...

Recruiting

Effect of DHEA on Patients With Poor Ovarian Responds

Subfertility

China
University of Birmingham

Recruiting

Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary Syndrome (11OXO-PCOS)

Polycystic Ovary Syndrome

United Kingdom
Center for Human Reproduction

Terminated

Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility (DHEAFert)

Primary Ovarian Insufficiency | Unexplained Infertility

United States
Kaohsiung Veterans General Hospital.

Recruiting

Effectiveness of Adjuvant Supplements Prior to in IVF

Dietary Supplements

Taiwan
University of Arkansas
AMAG Pharmaceuticals, Inc.

Recruiting

Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors

Vaginal Atrophy | Breast Cancer Female | Postmenopausal Symptoms | Long-term Survivors

United States
National Center for Research Resources (NCRR)
Northwestern University

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Beni-Suef University

Not yet recruiting

The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders

Poor Responders

Egypt
National Center for Research Resources (NCRR)
Northwestern University

Completed

Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
National Center for Research Resources (NCRR)
Northwestern University

Completed

Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Meir Medical Center

Completed

Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment

Ovarian Stimulation

Israel
Chinese University of Hong Kong

Terminated

The Outcome of Chinese Women With Genitourinary Syndrome of Menopause Treated With Vaginal Dehydroepiandrosterone

Genitourinary Syndrome of Menopause

Hong Kong
Virginia Center for Reproductive Medicine

Terminated

The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve

Infertility

United States

Search clinical trials for: Dehydroepiandrosterone (DHEA)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations